Arata Nishimoto

ニシモトアラタ | Arata Nishimoto

Affiliation and department：

Research field (1)： Tumor biology

Research theme for competitive and other funds (8)：

2015 - 2018 Mechanisms of enhanced tumor growth during compensatory lung growth after major lung resection
2013 - 2016 Mechanism identification and Developing a novel method for therapy against lung cancer invasion via cancer-associated fibroblasts in pulmonary emphysema
2014 - 2016 c-MYC, HIF-1による大腸癌の抗癌剤抵抗性獲得機構の解明
2012 - 2014 Elucidation of the role of Jab1 in malignant progression of colon cancer
2009 - 2011 Study of the regulatory mechanism of ETAR and ETBR level by receptor binding protein and the relevance between clinical significance and endothelin receptor level.

Show all

Papers (36)：

Arata Nishimoto, Yoshihiro Takemoto, Toshiro Saito, Hiroshi Kurazumi, Toshiki Tanaka, Eijiro Harada, Bungo Shirasawa, Kimikazu Hamano. Nuclear β-catenin expression is positively regulated by JAB1 in human colorectal cancer cells. Biochemical and Biophysical Research Communications. 2020. 533. 3. 548-552
西本新, 久永拓郎, 桂春作, 藤宮龍也, 白澤文吾. 新入生に対する医学入門の最近3年間の現状と今後の課題(第2報). 山口医学. 2019. 68. 4. 145-149
YUKI SUEHIRO, YOSHIHIRO TAKEMOTO, ARATA NISHIMOTO, KOJI UENO, BUNGO SHIRASAWA, TOSHIKI TANAKA, NARUJI KUGIMIYA, ATSUSHI SUGA, EIJIRO HARADA, KIMIKAZU HAMANO. Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer. Anticancer Research. 2018. 38. 11. 6225-6230
Naruji Kugimiya, Arata Nishimoto, Tohru Hosoyama, Koji Ueno, Yoshihiro Takemoto, Eijiro Harada, Tadahiko Enoki, Kimikazu Hamano. JAB1-STAT3 activation loop is associated with recurrence following 5-fluorouracil-based adjuvant chemotherapy in human colorectal cancer. Oncology letters. 2017. 14. 5. 6203-6209
Daichi Kawamura, Yoshihiro Takemoto, Arata Nishimoto, Koji Ueno, Tohru Hosoyama, Bungo Shirasawa, Toshiki Tanaka, Naruji Kugimiya, Eijiro Harada, Kimikazu Hamano. Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells. Oncology Reports. 2017. 38. 5. 3238-3244

ｍore...

MISC (17)：

竹内由利子, 久永拓郎, 西本新, 桂春作, 白澤文吾. コロナ禍で実施した地域医療実習における学修姿勢の変化. 医学教育. 2022. 53. Suppl. 237-237
久永拓郎, 竹内由利子, 西本新, 桂春作, 白澤文吾. コロナ禍における「臨床実習の到達目標」のオンライン自己評価の動向. 医学教育. 2022. 53. Suppl. 244-244
末廣祐樹, 竹本圭宏, 西本新, 上野耕司, 白澤文吾, 田中俊樹, 釘宮成二, 菅淳, 原田栄二郎, 濱野公一. ヒト大腸癌細胞株に対する5-FUとDclk1阻害薬の併用効果の検証. 日本消化器外科学会総会. 2018. 73回. 950-950
Takahiro Horinouchi, Tsunaki Higa, Tadashi Nishiya, Hiroyuki Aoyagi, Hiroyuki Suzuki, Arata Nishimoto, Soichi Miwa. Negative regulation of endothelin type A receptor-operated TRPC6 by adenylate cyclase/cAMP/PKA pathway. JOURNAL OF PHARMACOLOGICAL SCIENCES. 2011. 115. 112P-112P
Takahiro Horinouchi, Tsunaki Higa, Hiroshi Asano, Arata Nishimoto, Tadashi Nishiya, Soichi Miwa. Molecular mechanisms for endothelin type A receptor-operated Ca2+ entry via TRPC3 and TRPC6. JOURNAL OF PHARMACOLOGICAL SCIENCES. 2010. 112. 95P-95P

ｍore...

Education (3)：

Professional career (1)：

Work history (7)：

Show all

Awards (2)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page